HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.

Abstract
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.
AuthorsD G Baker, B I Diamond, G Gillette, M Hamner, D Katzelnick, T Keller, T A Mellman, E Pontius, M Rosenthal, P Tucker
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 122 Issue 4 Pg. 386-9 (Dec 1995) ISSN: 0033-3158 [Print] Germany
PMID8657838 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Monoamine Oxidase Inhibitors
  • Piperidines
  • brofaromine
Topics
  • Adult
  • Aged
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors (adverse effects, therapeutic use)
  • Piperidines (adverse effects, therapeutic use)
  • Stress Disorders, Post-Traumatic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: